Applied Evidence

Hypertriglyceridemia: A strategic approach

Author and Disclosure Information

 

References

Exercise. Thirty minutes a day of moderate-intensity exercise is associated with a significant drop in postprandial TG. This benefit can last as long as 3 days, suggesting a goal of at least 3 days a week of an active lifestyle. Such a program can include intermittent aerobics or mild resistance exercise.19

Healthy eating habits. The difference between a low-fat, high-carbohydrate diet and a high-fat, low-carbohydrate diet is less important than the overall benefit of weight loss from either of these diets. Complex carbohydrates are recommended over simple carbohydrates. A low-carbohydrate diet in a patient with diabetes has been demonstrated to improve the TG level, irrespective of weight change.20

The risk of acute pancreatitis in the general population is 0.04%, but that risk increases to 8% to 31% for a person with hypertriglyceridemia

A Mediterranean diet can reduce the TG level by 10% to 15%, and is recommended over a low-fat diet.14 (This diet generally includes a high intake of extra virgin olive oil; leafy green vegetables, fruits, cereals, nuts, and legumes; moderate intake of fish and other meat, dairy products, and red wine; and low intake of eggs and sugars.) The American Heart Association recommends 2 servings of fatty fish a week for its omega-3 oil benefit of reducing ASCVD risk. Working with a registered dietician to assist with lipid lowering can produce better results than physician-only instruction on healthy eating.9

Alcohol consumption. Complete cessation or moderation of alcohol consumption (1 drink a day/women and 2 drinks a day/men*) is recommended to improve HTG. Among secondary factors, alcohol is commonly the cause of an unusually high elevation of the TG level.14

Smoking cessation. Smoking increases the postprandial TG level.10 Complete cessation for just 1 year can reduce a person’s ASCVD risk by approximately 50%. However, in a clinical trial,22 smoking cessation did not significantly decrease the TG level—possibly because of the counterbalancing effect of weight gain following cessation.

Continue to: Medical therapy

Pages

Recommended Reading

FOURIER: Evolocumab follow-up shows no cognitive adverse effects
MDedge Family Medicine
Diastolic dysfunction is a common risk factor for cognitive decline
MDedge Family Medicine
Multisociety roadmap eyes restarting elective cardiac cases
MDedge Family Medicine
AHA emphasizes the need for cardio-obstetrics teams
MDedge Family Medicine
New angiotensin studies in COVID-19 give more reassurance
MDedge Family Medicine
FDA approves dapagliflozin for low-EF heart failure
MDedge Family Medicine
Results from 11 AHA-funded COVID-19 studies expected within months
MDedge Family Medicine
Adolescent obesity, diabetes linked to atherosclerotic signs
MDedge Family Medicine
Coffee drinking linked with fewer arrhythmias
MDedge Family Medicine
Evidence builds linking anticoagulation to COVID-19 survival
MDedge Family Medicine